Onderneming Amplia Therapeutics Limited
Aandelen
ATX
AU0000023822
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,06 AUD | -3,23% | -7,69% | -25,00% |
Vakgebied
Verkoop per activiteit
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Focal Adhesion Kinase
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 31-05-00 | |
Tim Luscombe
DFI | Director of Finance/CFO | - | 25-09-23 |
Rhiannon Jones
COO | Chief Operating Officer | - | 01-02-21 |
Charlotte Mulder
PRN | Corporate Officer/Principal | - | - |
Mark Devlin
PRN | Corporate Officer/Principal | - | - |
Andrew Cooke
SEC | Corporate Secretary | 62 | 11-10-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Cooke
SEC | Corporate Secretary | 62 | 11-10-13 |
Robert Peach
BRD | Director/Board Member | 68 | 02-09-15 |
Warwick Tong
CHM | Chairman | - | 04-05-18 |
Founder | - | 31-05-00 | |
Jane Bell
BRD | Director/Board Member | - | 12-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 271 608 953 | 230 720 249 ( 84,95 %) | 0 | 84,95 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,00% | 7,95 mln. | |
+8,90% | 105 mld. | |
-0,99% | 104 mld. | |
+5,79% | 22,94 mld. | |
-12,34% | 22,34 mld. | |
-7,01% | 19,25 mld. | |
-37,08% | 17,08 mld. | |
-8,94% | 16,96 mld. | |
+7,83% | 14,16 mld. | |
+38,32% | 12,63 mld. |